Please assess the completion status of the following clinical trial:

Trial Title: PEMF Therapy to Treat Lingering Symptoms of Lyme Disease After Treatment With Antibiotics

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis from GP confirming Lyme disease and/or~* Blood test confirming Lyme disease and/or~* Symptoms that correlate to Lyme disease without diagnosis from GP. This is called self diagnosis and because 80% of the trial is focused on treating symptoms and not the spirochetes, bacteria or small cysts of Lyme disease, the results are expected to be largely the same~Exclusion Criteria:~* Persons currently undergoing antibiotic treatment for Lyme or other conditions~* Persons who were prescribed antibiotics but did not or could not take them

- Gender: ALL
- Minimum Age: 14 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- PEMF Therapy (Type: EXPERIMENTAL): Pulsed ElectroMagnetic Field Therapy using square wave forms. In addition to set, pre-defined frequencies to aid the body's own immune system, the Artificial Intelligence incorporated into the software used will suggest a variety of frequencies to be administered during treatment. Due to the software's selection, these recommendations or selections from the software will likely be different in each treatment session.
- Control (Type: NO_INTERVENTION): Control group will not receive treatment.

Based on this trial design, predict the completion outcome and termination type (if applicable).